Demonstration venue · read-only. Every page can be browsed; the buttons that would change it are switched off. Create an account to run TaxoReview on your own data. A simulation from public publication records: the people listed were not invited and did not agree to review.
? Tutorial for this page

Carlo Di Bello

dblp:74/5650 · DBLP profile ↗
← Back
1ranked-venue papers
0as first author
0since 2021 · last 2003
—ORCID · none

Domains — the database's venue-derived domains; a paper can count in several

Applied, interdisciplinary, general and emerging computing · 1

Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.

Interdisciplinary, comprehensive, and emerging computing
1 paper
Bioinformatics and computational biology · 100%

Topics — the 3 heaviest of 3, each with the papers that count most for it

TopicWeightPapersLastEvidence papers
Bioinformatics and computational biology
cancer genomics
0.012003
PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003
Bioinformatics and computational biology › gene expression analysis
gene expression classification
0.012003
PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003
Bioinformatics and computational biology › functional genomics
marker gene identification
0.012003
PCA disjoint models for multiclass cancer analysis using gene expression data · Bioinform. 2003

Methods — techniques the papers use, named apart from their topics

principal component analysis · 0.0disjoint principal component models · 0.0
YearPublicationVenuePosition
2003 PCA disjoint models for multiclass cancer analysis using gene expression data
abstract
MOTIVATION: Microarray expression profiling appears particularly promising for a deeper understanding of cancer biology and to identify molecular signatures supporting the histological classification schemes of neoplastic specimens. However, molecular diagnostics based on microarray data presents major challenges due to the overwhelming number of variables and the complex, multiclass nature of tumor samples. Thus, the development of marker selection methods, that allow the identification of those genes that are most likely to confer high classification accuracy of multiple tumor types, and of multiclass classification schemes is of paramount importance. RESULTS: A computational procedure for marker identification and for classification of multiclass gene expression data through the application of disjoint principal component models is described. The identified features represent a rational and dimensionally reduced base for understanding the basic biology of diseases, defining targets for therapeutic intervention, and developing diagnostic tools for the identification and classification of multiple pathological states. The method has been tested on different microarray data sets obtained from various human tumor samples. The results demonstrate that this procedure allows the identification of specific phenotype markers and can classify previously unseen instances in the presence of multiple classes.
Silvio Bicciato, Alessandra Luchini, Carlo Di Bello
Bioinform.3